MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation launches a new assay validated for assessing the viability of cells in three-dimensional (3D) microtissue model systems. CellTiter-Glo® 3D Cell ...

What do the high cost of cancer drug development and inconsistencies in many cancer research studies have in common? The most direct answer is that the in vitro models currently in use do not ...

Keeping Cells “Happy” and Healthy Helps Support Complex Multiplexed Assays Maintaining cell viability throughout the cell culture process is virtually a nonissue in current drug discovery efforts. But ...

An increasing body of research indicates that more translational and relevant evaluations can be made utilizing 3D organoids and micro-tissues as opposed to 2D monolayer cell models. This is most ...

The utilization of multi-cell tumor spheroids as an oncology research model has quickly increased because of a greater understanding of the effects of the tumor microenvironment, along with the ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the cell viability assays market and it is poised to grow by USD 1.40 billion during 2020-2024, progressing at a CAGR of over 8% during the ...